Improved analytical validation and pharmacokinetics of valsartan using HPLC with UV detection

Archives of Pharmacal Research

Volumn 31, Issue 8, 2008, Pages 1055-1059

  Piao, Zong Zhu ^a   Lee, Eung Seok ^a   Tran, Huyen Thi Thanh ^a   Lee, Beom Jin ^a  

^a Kangwon National University   (South Korea)

Author keywords

Analytical validation; Extraction efficiency; HPLC UV detection; Pharmacokinetics; Valsartan

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DRUG DERIVATIVE; PLASMA PROTEIN; SOLVENT; TETRAZOLE DERIVATIVE; VALINE; VALSARTAN;

ADULT; ARTICLE; CALIBRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METABOLISM; MICROCAPSULE; PROTEIN BINDING; REPRODUCIBILITY; STANDARD; ULTRAVIOLET SPECTROPHOTOMETRY;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PROTEINS; CALIBRATION; CAPSULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MALE; PROTEIN BINDING; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TETRAZOLES; VALINE;

EID: 51849105198     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1268-4     Document Type: Article

References (14)

1. C. Brunella D. M. Clelia I. Maria M. Agnese 2006 Improvement of Solubility and Stability of valsartan by Hydroxypropyl-β-Cyclodextrin J. Incl. Phenom., Macrocycl. Chem. 54 289 294
2. C. Czendlik A. Sioufi G. Preiswerk H. Howald 1997 Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol Eur. J. Clin. Pharmacol. 52 451 459
3. N. Daneshtalab R. Z. Lewanczuk F. Jamali 2002 High-performance liquid chromatographic analysis of angiotensin II receptor antagonist valsartan using a liquid extraction method J. Chromatogr. B. 766 345 349
4. N. Erk 2003 Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by liquid chromatography J. Chromatogr. 784 195 201
5. G. Flesch P. Müller P. Lioyd 1997 Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man Eur. J. Clin. Pharmacol. 52 115 120
6. L. González J. A. López R. M. Alonso R. M. Jiménez 2002 Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection J. Chromatogr. A.949 49 60
7. Guidance for industry: Bioanalytical method validation, U.S. Department of Health and Human Services, Food and Drug Administration. Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM). May 2001, http//www.fda.gov/cder/guidance/index.htm.
8. N. Koseki H. Kawashita H. Hara M. Niina M. Tanaka R. Kawai Y. Nagae N. Masuda 2007 Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometry J. Pharm. Biomed. Anal. 43 1769 1774
9. H. Li Y. G. Wang Y. Jiang Y. B. Tang J. Wang L. Zhao J. K. Gu 2007 A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma J. Chromatogr. B. 852 436 442
10. J. Macek J. Klima P. Ptáèek 2006 Rapid determination of valsartan in human plasma by protein precipitation and high-performance liquid chromatography J. Chromatogr. B. 832 169 172
11. P. Müller G. Flesch M. D. Gasparo M. Gasparini H. Howald 1997 Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects Eur. J. Clin. Pharmacol. 52 441 449
12. E. K. Schmidt K.-H. Antonin G. Flesch P.-A. Racine 1998 An interaction study with cimetidine and the new angiotensin II antagonist valsartan Eur. J. Clin. Pharmacol. 53 451 458
13. S. Tatar S. Salk 2002 Comparison of UV and second derivative- spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulation J. Pharm. Biomed. Anal. 30 371 375
14. 14C]-radiolabelled valsartan in healthy male volunteers after a single oral dose Xenobiotica 27 59 71